|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/7088 | |||
| C12N 9/22 | |||
| C12N 15/86 | |||
| A61K 48/00 |
| (11) | Patento numeris | 3116997 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15714320.7 |
| Europos patento paraiškos padavimo data | 2015-03-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-01-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-05-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/019790 |
| Data | 2015-03-10 |
| (87) | Numeris | WO 2015/138510 |
| Data | 2015-09-17 |
| (30) | Numeris | Data | Šalis |
| 201461950733 P | 2014-03-10 | US | |
| 201462036576 P | 2014-08-12 | US |
| (72) |
MAEDER, Morgan, L., US
BUMCROT, David, A., US
SHEN, Shen, US
|
| (73) |
Editas Medicine, Inc.,
11 Hurley Street, Cambridge, MA 02141,
US
|
| (54) | CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING LEBER`S CONGENITAL AMAUROSIS 10 (LCA10) |
| CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING LEBER`S CONGENITAL AMAUROSIS 10 (LCA10) |